Picard Medical (PMI) Fundamental Analysis: Revenue, Earnings & Valuation

1.12 / 10

Underperform

Financial evaluation reveals inadequate fundamentals, scoring only 1.1/10. Key weaknesses include negative asset-to-market value and revenue-to-market value differences, low cash-to-market value, and poor profitability metrics like ROA and net profit margins. Only the interest coverage ratio and net profit to total profit ratio show relatively stronger positions, but they are insufficient to offset other deficits.

Analysis Checks(5/10)

Revenue-MV

Value-4.37

Score2/3

Weight-0.30%

1M Return0.09%

ROA (%)

Value-177.24

Score0/3

Weight17.02%

1M Return-7.78%

Net profit attributable to parent company shareholders / Net profit (%)

Value100.00

Score2/3

Weight5.72%

1M Return-1.71%

Net income-Revenue

Value-0.17

Score1/3

Weight8.07%

1M Return-2.55%

Cash-UP

Value-0.06

Score2/3

Weight13.93%

1M Return-4.86%

Annualized net profit margin on total assets (%)

Value-236.32

Score0/3

Weight17.02%

1M Return-7.78%

Interest coverage ratio (EBIT / Interest expense) (%)

Value15.48

Score2/3

Weight6.44%

1M Return-1.95%

Asset-MV

Value-0.50

Score0/3

Weight10.80%

1M Return-3.57%

Cash-MV

Value-0.07

Score1/3

Weight15.31%

1M Return-5.64%

Net profit / Total profit (%)

Value100.14

Score2/3

Weight6.00%

1M Return-1.71%

Is PMI fundamentally strong?

PMI scores 1.12/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, -661.82% net margin, -4.58 P/E ratio, 17.39 P/B ratio, and 0.00% earnings growth, these metrics solidify its Underperform investment rating.